Covid-19 vaccines: authorised
13. Oktober 2022 – The European Commission authorised the conversion of the conditional marketing authorisation for Spikevax to standard marketing authorisation.
For more information, see here.
13. Oktober 2022 – The European Commission authorised the conversion of the conditional marketing authorisation for Spikevax to standard marketing authorisation.
For more information, see here.